The Effect of Beta-Blockers and Aspirin on Hemostasis and Endothelial Function After Acute Mental Stress
Arteriosclerosis, Stress, Psychological
About this trial
This is an interventional prevention trial for Arteriosclerosis focused on measuring Randomized controlled trial, Blood platelets, Hemostasis, Stress, psychological, Adrenergic beta-antagonists, Aspirin, Endothelium, Arteriosclerosis
Eligibility Criteria
Inclusion Criteria: Life-time non-smoker or non-smoker for more than a year, native language Swiss-German, systolic blood pressure <160 mm Hg, diastolic blood pressure <100 mm Hg. Subjects must have a body mass index that is not considered to be a cardiovascular risk factor, i.e. ≤ 26.5 kg/m2. Exclusion Criteria: Individuals reporting cardiovascular disease, renal disorders, endocrine disorders, hepatopathy, psychiatric disorders or who take regular medication for any of these conditions. Persons are excluded, who report to drink >5 cups (0.15 l each) of brewed coffee (> 500 mg caffeine) a day, or who report drink more than 1.0 l beer and 0.45 l wine per day, respectively. All subjects on regular beta-blocking or aspirin medication are excluded from the study. Participants will be required not to take aspirin or any other non-steroidal anti-inflammatory drug during the study period, beginning 10 days prior to the first study medication.
Sites / Locations
- Institute of Behavioral Sciences, Swiss Federal Institute of Technology